Expert Interview
A Third Look: Discussing the headline results from the EAGLE-1 phase III trial for Gepotidacin an experimental antibiotic for treatment of Gonorrhoea
Ticker(s): GSKInstitution: Permanent Medical Group
- Practicing ID physician since 2011
- sees 5 new patients per day who have weight related cardiovascular complications
- over the past decade, I estimate an average of 5 cases seen per year of Dengue
- aware of the JNJ01802 results that were made available at ASTMH
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
